Cancer is a leading cause of death. Venous thromboembolism (VTE) is an often-overlooked cause of morbidity and mortality in cancer patients that can be readily prevented and treated. Actions are needed to reduce the morbidity and mortality of patients with cancer-associated thrombosis (CAT). There is a need to increase awareness of the impact of CAT on cancer patients’ morbidity and mortality, on their quality of life and to understand the importance of more effective preventions and treatments of VTE in cancer patients. Moreover, it is of great importance to systematically assess the risk of VTE in regard to patients, cancer and treatment-related factors. Unfortunately, there are unmet clinical needs in the prevention and treatment of canc...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Emerging d...
Venous thromboembolism (VTE) is a potentially life-threatening condition that can be associated with...
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial events) is highly ...
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognise...
Background: Venous thromboembolism (VTE) remains one of the most important causes of mortality and m...
Cancer-associated thrombosis (CAT) adversely affects the quality of life and survival of people with...
Cancer-associated venous thromboembolism (CAT) has detrimental impact on patients' clinical outcomes...
Cancer patients represent a growing population with drastically difficult care and a lowered quality...
Over the past 20 years, venous thromboembolism (VTE) has become the second cause of death in cancer ...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
International audienceThe management of cancer-associated thrombosis (CAT) is an evolving area. With...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Introduction: Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in pat...
Cancer represents a well recognized risk factor for venous thromboembolism. Patients with cancer hav...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Cancer-ass...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Emerging d...
Venous thromboembolism (VTE) is a potentially life-threatening condition that can be associated with...
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial events) is highly ...
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognise...
Background: Venous thromboembolism (VTE) remains one of the most important causes of mortality and m...
Cancer-associated thrombosis (CAT) adversely affects the quality of life and survival of people with...
Cancer-associated venous thromboembolism (CAT) has detrimental impact on patients' clinical outcomes...
Cancer patients represent a growing population with drastically difficult care and a lowered quality...
Over the past 20 years, venous thromboembolism (VTE) has become the second cause of death in cancer ...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
International audienceThe management of cancer-associated thrombosis (CAT) is an evolving area. With...
Venous thromboembolism (VTE) is a frequent complication in patients with cancer and is associated wi...
Introduction: Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in pat...
Cancer represents a well recognized risk factor for venous thromboembolism. Patients with cancer hav...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Cancer-ass...
Venous thromboembolism (VTE) is a common complication in patients with malignant disease. Emerging d...
Venous thromboembolism (VTE) is a potentially life-threatening condition that can be associated with...
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial events) is highly ...